Fluidigm corporation:1157584 [17-064228]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700624P
- Awardee
-
Standard Biotools Inc. UEI Q7U7QSDD32W4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,089
Award facts
- Contract value 100% obligated
- $6,088.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 7, 2017, with a ceiling value of $6,088.50. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 9, 2017. Pricing is firm fixed price. The specific requirements are not detailed in the source material.
Quick answers
Who was awarded contract HHSN261201700624P?
HHSN261201700624P was awarded to Standard Biotools Inc. by National Cancer Institute (National Institutes of Health) on September 7, 2017.
How much is contract HHSN261201700624P worth?
The government has obligated $6,089 on HHSN261201700624P.
Was contract HHSN261201700624P competed?
The extent of competition for HHSN261201700624P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award